Jump to content


Hang onto your hat: Sclero Forums Upgrade May 14-21, 2017!! The Forums will be offline for up to 4 days, and then will return with an entirely new look and feel.


Photo

Asymmetrical dimethylarginine (ADAM) in systemic sclerosis-related pulmonary arterial hypertension (PAH)


  • Please log in to reply
No replies to this topic

#1 janey

janey

    Platinum Member

  • ISN Support Specialists
  • PipPipPipPipPipPipPipPipPipPip
  • 2,113 posts
  • Location:New Mexico

Posted 31 October 2008 - 05:21 AM

Asymmetrical dimethylarginine (ADAM) in systemic sclerosis-related pulmonary arterial hypertension (PAH).

In patients with SScPAH, increased ADMA serum levels and their negative association with exercise capacity suggests that the nitric oxide pathway is involved in the development of pulmonary vascular disease. T. Dimitroulas. Rheumatology 2008 47(11):1682-1685. (Also see: Pulmonary Hypertension)

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
Janey Willis
ISN Support Specialist
(Retired) ISN Assistant Webmaster
(Retired) ISN News Director
(Retired) ISN Technical Writer for Training Manuals
International Scleroderma Network (ISN)